Literature DB >> 1351484

Restriction endonuclease-fragment polymorphisms of oral viridans streptococci, compared by conventional and field-inversion gel electrophoresis.

J D Rudney1, E K Neuvar, A H Soberay.   

Abstract

Oral streptococci formerly classified as Streptococcus sanguis or Streptococcus mitis have recently been divided into four species. Two additional species have also been proposed for this group. Each species is genetically distinct, but they have many traits in common, which makes it difficult for clinical isolates to be identified by phenotypic tests. Genotypic comparison may provide an alternative approach. This study used DNA fingerprint analysis for comparison of genotypes of 21 reference strains--classified as Streptococcus gordonii, Streptococcus sanguis, Streptococcus oralis, "Streptococcus parasanguis", or "Streptococcus crista" in previous DNA hybridization studies--and 17 clinical and laboratory strains placed in those groups on the basis of phenotypic tests. HinDIII and PvuII digests were run in conventional horizontal agarose gels. SfiI digests of reference strains and two laboratory strains were run in field-inversion gels. Fingerprint patterns were compared by visual examination, cluster analysis of densitometric traces, and lane-matching software. Only two "S. crista" strains and two parent mutant lineages showed fingerprint patterns that were identical by visual examination. Fingerprint patterns of all other strains were unique. Cluster analysis results could not be considered valid, since replicate lanes in different gels were not grouped together. HinDIII and PvuII digests contained too many bands for correct matching by lane-matching software. SfiI digests were correctly matched by computer, with the same results as visual examination. Results indicate that the diversity of strains within these streptococcal species was too great to permit species identification by DNA fingerprint patterns. This genotypic diversity suggests that isolates from unrelated hosts may have been separate for long periods of time.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351484     DOI: 10.1177/00220345920710051001

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  8 in total

1.  PCR-Based methods for genotyping viridans group streptococci.

Authors:  S Alam; S R Brailsford; R A Whiley; D Beighton
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Identification of clinically relevant viridans group streptococci by phenotypic and genotypic analysis.

Authors:  C Teles; A Smith; G Ramage; S Lang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-28       Impact factor: 3.267

3.  A streptococcal adhesion system for salivary pellicle and platelets.

Authors:  K Gong; T Ouyang; M C Herzberg
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

4.  Prevalence of the amylase-binding protein A gene (abpA) in oral streptococci.

Authors:  A E Brown; J D Rogers; E M Haase; P M Zelasko; F A Scannapieco
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

5.  Species identification of oral viridans streptococci by restriction fragment polymorphism analysis of rRNA genes.

Authors:  J D Rudney; C J Larson
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

6.  Use of restriction fragment polymorphism analysis of rRNA genes to assign species to unknown clinical isolates of oral viridans streptococci.

Authors:  J D Rudney; C J Larson
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

7.  Racial Healthcare Disparities: A Social Psychological Analysis.

Authors:  Louis A Penner; Nao Hagiwara; Susan Eggly; Samuel L Gaertner; Terrance L Albrecht; John F Dovidio
Journal:  Eur Rev Soc Psychol       Date:  2013

8.  Identification of Streptococcus sanguinis with a PCR-generated species-specific DNA probe.

Authors:  Yihong Li; Yaping Pan; Fengxia Qi; Page W Caufield
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.